Aims: To investigate the role of Toll-like receptor 3 (TLR3) in mouse paraquat-induced acute renal injury.
Materials And Methods: Acute renal injury was established in C57BL/6J mice by intraperitoneal injection of paraquat (28 mg/kg). The mice were also injected intraperitoneally with TLR3 agonist poly I:C (20 mg/kg) or TLR3/dsRNA complex inhibitor (1 mg) 1 h before paraquat exposure. At 72 hour post paraquat exposure, the mice were sacrificed and the blood and renal tissues were collected to examine TLR3 expression in renal tissues, pathological injury in renal tissues, renal function, inflammation, and cell apoptosis.
Key Findings: After paraquat exposure, TLR3 expression in mouse renal tissues was significantly increased, and pathological changes to the renal tissues and remarkable renal impairment were present. Compared to the paraquat group, the poly I:C group showed no significant difference in renal pathology, renal function, inflammation, or cell apoptosis. However, TLR3 inhibitor treatment significantly alleviated injury to the renal tissues, improved renal function, inhibited NF-κB activation, suppressed the infiltration of neutrophils, and lessened the expression of IL-1β, TNF-α, and keratinocyte chemoattractant (KC) in renal tissues. TLR3 inhibitor treatment also suppressed the activation of caspase-8 and caspase-3 and reduced apoptosis in the renal tissues.
Significance: Paraquat exposure significantly upregulates TLR3 expression in renal tissues, and activation of the TLR3 signaling pathway is an important contributor to paraquat nephrotoxicity. TLR3 activation exacerbates inflammation and cell apoptosis in renal tissues by activating NF-κB and caspase-8, thus promoting paraquat-induced acute renal injury.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.lfs.2019.03.029 | DOI Listing |
Purpose: To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery (PCS) among patients with stage III-IV epithelial ovarian, fallopian tube, or primary peritoneal cancer (epithelial ovarian cancer [EOC]).
Methods: A multidisciplinary Expert Panel convened and updated the systematic review.
Results: Sixty-one studies form the evidence base.
Iran J Med Sci
December 2024
Department of Medical Physiology, College of Medicine, Zagazig University, Al-Sharquia, Egypt.
Background: The risk of cardiovascular disease (CVD) in patients with chronic kidney disease (CKD) is estimated to be far greater than that in the general population. Adropin regulates endothelial function and may play a role in the pathogenesis of CVD. Angiotensin-converting enzyme inhibitor (ACEI) treatment was reported to have a protective effect on both renal and cardiovascular function.
View Article and Find Full Text PDFCureus
December 2024
Internal Medicine, Hospital da Senhora da Oliveira, Guimarães, PRT.
Systemic lupus erythematosus (SLE) is a multisystemic connective tissue disease with a wide range of clinical and laboratory manifestations. The diagnosis of SLE is often challenging due to the great variability in its presentation, and treatment should be individualized according to the patient's manifestations and affected organs. We present the clinical case of a 25-year-old female who developed SLE with severe hematological and renal involvement as first manifestations, including hemolytic anemia, thrombocytopenia, and nephrotic syndrome.
View Article and Find Full Text PDFIntroduction: Living-donor kidney transplantation (LDKT) is often performed using hand-assisted laparoscopic donor nephrectomy (HALDN). Adherent perinephric fat (APF) can complicate HALDN, increasing operative time. The Mayo Adhesive Probability (MAP) score predicts APF preoperatively.
View Article and Find Full Text PDFFront Pharmacol
January 2025
Department of Anaesthesiology and Intensive Care Medicine, Faculty of General Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Târgu Mureș, Romania.
Knowledge of drug pharmacokinetics and tissue distribution is precious for ensuring patient safety and optimizing treatments. The varied use of local anesthetics, as well as the fact that anesthetics can sometimes have low therapeutic indices and numerous adverse drug reactions, makes any novel pharmacokinetics information valuable. The present manuscript describes a pharmacokinetic study of ropivacaine carried out after plane block anesthesia on an animal model, using high sensitivity, accurate, and precise LC-MS/MS bioanalysis.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!